Pfizer meningitis vaccine wins U.S. approval

October 29, 2014 6:52 PM

14 0

Pfizer meningitis vaccine wins U.S. approval

(Reuters) - Pfizer Inc has won U.S. approval for its Trumenba vaccine against meningitis, a potentially deadly bacterial disease that has recently caused outbreaks on college campuses, the U.S. Food and Drug Administration said on Wednesday.

Trumenba, approved in individuals 10 to 25 years of age, has been considered one of the most important products in Pfizer's drug pipeline. It was granted accelerated approval following tests in 4,500 people in the United States, Europe and Australia.

Also read: Counterterrorism law replacing France's state of emergency adopted

Read more

To category page